Biofactura INC

$67M obligated·3 awards·2 agencies·2 NAICS

Federal Contracts

Showing award actions 1–10 of 10 funded award actions, most recent first.

Contracts with positive obligations: 3
Funded award actions shown: 10
Obligations shown: $67M
Awarding agencies: 2

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of September 23, 2025. Source: USAspending federal award records.

Date	Agency	PIID	NAICS	Description	Amount
Sep 19, 2024	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119C00054	541714	THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS	$7.8M
Sep 20, 2023	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119C00054	541714	THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS	$16M
Jun 16, 2023	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119C00054	541714	THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS	$928K
Mar 7, 2023	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119C00054	541714	THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS	$1.7M
Jun 28, 2022	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119C00054	541714	THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS	$16M
May 23, 2022	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119C00054	541714	THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS	$748K
Feb 10, 2021	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119C00054	541714	THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS	$13M
Jun 11, 2020	Department of DefenseDEFENSE THREAT REDUCTION AGENCY	HDTRA120C0033	541714	PHASE II SBIR FOR PROCESS DEVELOPMENT AND MANUFACTURE OF AN ANTIBODY-BASED THERAPY AGAINST MARBURGVIRUS.	$999K
Sep 20, 2019	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119C00054	541714	THIS CONTRACT INCLUDES PRECLINICAL AND MANUFACTURING DEVELOPMENT ACTIVITIES INCLUDING CELL LINE DEVELOPMENT PROCESS DEVELOPMENT NON-CLINICAL EFFICACY STUDIES NON-CLINICAL SAFETY STUDIES MANUFACTURING ACTIVITIES CLINICAL ACTIVITIES AND ALL AS	$9.5M
Apr 12, 2018	Department of DefenseW4PZ USA MED RSCH ACQUIS ACT	W81XWH18C0082	325411	CBD SBIR 17.2 PHASE I PROPOSAL #C171-005-0003, PROCESS DEVELOPMENT AND MANUFACTURE OF AN ANTIBODY-BASED THERAPY AGAINST MARBURGVIRUS	$150K

Get Alerted Before Biofactura INC's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free